Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Sales | 7,477,700 | 7,230,200 | 6,950,000 | 6,406,000 | 5,671,500 |
| Cost of Goods | 1,772,000 | 2,024,300 | 2,200,600 | 2,259,400 | 2,062,300 |
| Gross Profit | 5,705,700 | 5,205,900 | 4,749,400 | 4,146,600 | 3,609,200 |
| Operating Expenses | 4,040,400 | 3,762,800 | 3,496,500 | 3,093,200 | 2,641,300 |
| Operating Income | 1,665,300 | 1,443,400 | 1,253,500 | 1,053,800 | 968,200 |
| Interest Expense | 106,500 | 103,400 | 430,100 | 132,500 | 126,000 |
| Other Income | -707,400 | 194,800 | 120,300 | 182,000 | 74,300 |
| Pre-tax Income | 851,400 | 1,534,800 | 943,700 | 1,103,300 | 916,500 |
| Income Tax | 191,300 | 438,600 | 218,400 | 297,900 | 231,300 |
| Net Income Continuous | 1,183,688 | 1,072,200 | 722,295 | 801,200 | 681,100 |
| Net Income Discontinuous | 0 | -282,600 | 0 | 0 | 0 |
| Net Income | $657,500 | $810,900 | $722,100 | $801,200 | $681,100 |
| EPS Basic Total Ops | 0.17 | 0.21 | 0.18 | 0.20 | 0.17 |
| EPS Basic Continuous Ops | 0.31 | 0.27 | 0.18 | 0.20 | 0.17 |
| EPS Basic Discontinuous Ops | N/A | -0.07 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.17 | 0.21 | 0.18 | 0.20 | 0.17 |
| EPS Diluted Continuous Ops | 0.31 | 0.27 | 0.18 | 0.20 | 0.17 |
| EPS Diluted Discontinuous Ops | N/A | -0.07 | N/A | N/A | N/A |
| EBITDA(a) | $1,923,500 | $1,707,300 | $1,497,600 | $1,278,600 | $1,175,300 |